Breast Cancer Research and Treatment

, Volume 87, Issue 3, pp 291–296

Breast cancer aggressiveness and racial disparity

  • Donald E. Henson
  • Steven R. Patierno
Article

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Eley JW, Hill HA, Chen VW, Austin DF, Wesley MN, Muss HB, Greenberg RS, Coates RJ, Correa P, Redmond CK, Hunter CP, Herman AA, Kurman R, Blacklow R, Shapiro S, Edwards BK: Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 272: 947–954, 1994Google Scholar
  2. 2.
    Aziz H, Hussain F, Sohn C, Mediavillo R, Saitta A, Hussain A, Brandys M, Homel P, Rotman M: Early onset of breast carcinoma in African American women with poor prognostic factors. Am J Clin Oncol. 22: 436–440, 1999Google Scholar
  3. 3.
    Lyman GH, Kuderer NM, Lyman SL, Cox CE, Reintgen D, Baekey P.: Importance of race on breast cancer survival. Ann Surg Oncol 4: 80–87, 1997Google Scholar
  4. 4.
    El-Tamer MB, Wait RBW: Age at presentation of African American and Caucasian breast cancer patients. J Am Coll Surg 188: 237–240, 1999Google Scholar
  5. 5.
    Joslyn SA, West MM: Racial differences in breast carci-noma survival. Cancer 88: 114–123, 2000Google Scholar
  6. 6.
    Maggard MA, O' Connell JB, Lane KE, Liu JH, Etzioni DA, Ko CY: Do young breast cancer patients have worse outcomes. J Surg Res 113: 109–113, 2003Google Scholar
  7. 7.
    Winchester DP, Osteen RT, Menck HR: The National Cancer Data Base report on breast carcinoma characteris-tics and outcomes in relation to age. Cancer 78: 1838–1834, 1996Google Scholar
  8. 8.
    Henson DE, Karami S: in pressGoogle Scholar
  9. 9.
    El-Tamer MB, Homel P, Wait RB: Is race a poor prognostic factor in breast cancer? J Am Coll Surgeons 189: 41–45, 1999Google Scholar
  10. 10.
    Middleton LP, Chen V, Perkins GH, Pinn V, Page D: Histopathology of breast cancer among African-American women. Cancer 97S: 253–257, 2003Google Scholar
  11. 11.
    Chen VW, Correa P, Kurman RJ, Wu XC, Eley JW, Austin D, Muss H, Hunter CP, Redmond C, Sobhan M, et al.: Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev 3: 127–135, 1994Google Scholar
  12. 12.
    Ownby HE, Frederick J, Russo J, Brooks SC, Swanson GM, Heppner GH, Brennan MT: Racial differences in breast cancer patients. J Natl Cancer Inst 75: 55–60, 1985Google Scholar
  13. 13.
    Simon MS, Severson RK: Racial differences in breast cancer survival: the interaction of socioeconomic status and tumor biology. Am J Obstet Gynecol 176(Suppl): 233–239, 1997Google Scholar
  14. 14.
    Henson DE, Chu KC, Levine PH: Histologic grade, stage, and survival in breast carcinoma;comparison of African American and Caucasian women. Cancer 98: 908–917, 2003Google Scholar
  15. 15.
    Elledge RM, Clark GM, Chamness GC, Osborne CK: Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst 86: 705–712, 1994Google Scholar
  16. 16.
    Chang S, Parker SL, Pham T, Buzdar AU, Hursting SD: Inflammatory breast carcinoma incidence and survival; the surveillance, epidemiology and end results program of the National Cancer Institute, 1975–1992. Cancer 82: 2366–2372, 1998Google Scholar
  17. 17.
    Beverly LN, Flanders WD, Go RC, Soong SJ: A compar-ison of estrogen and progesterone receptors in black and white breast cancer patients. Am J Public Health 77: 351–353, 1987Google Scholar
  18. 18.
    Gapstur SM, Dupuis J, Gann P, Collila S, Winchester DP: Hormone Receptor status of breast tumors in black, Hispanic, and non-Hispanic white women. An analysis of 13, 239 cases. Cancer 77: 1465–1471, 1996Google Scholar
  19. 19.
    Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN, Bedresian I, Knickerbocker C, Toyof-uku W, Lowe M, Herliczek TW, Bacus SS: Cyclin E and survival in patients with breast cancer. N Engl J Med 347: 1566–1575, 2002Google Scholar
  20. 20.
    Mourali N, Muenz LR, Tabbane F, Belhassen S, Bahi J, Levine PH: Epidemiologic features of rapidly progressing breast cancer in Tunisia. Cancer 46: 2741–2746, 1980Google Scholar
  21. 21.
    Kroman N, Wohlfahrt J, Andersen KW, Mouridsen HT, Westergaard T, Melbye M: Parity, age at rst childbirth and the prognosis of primary breast cancer. Br J Cancer 78: 1529–1533, 1998Google Scholar
  22. 22.
    Schouten LJ, Hupperets PS, Jager JJ, Volovics L, Wils JA, Verbeek AL, Blijham GH: Prognostic signi cance of etiological risk factors in early breast cancer. Breast Cancer Res Treat 43: 217–223, 1997Google Scholar
  23. 23.
    Lund E: Breast cancer mortality and the change in fertility risk factors at menopause;a prosptective study of 800, 000 married Norwegian women. Epidemiology 2: 285–188, 1991Google Scholar
  24. 24.
    Olsson H, Moller TR, Ranstam J, Borg A, Ferno M: Early oral contraceptive use as a prognostic factor in breast cancer. Anticancer Res 8: 29–32, 1998Google Scholar
  25. 25.
    Olsson H, Ranstam J, Baldetorp B, Ewers SB, Ferno M, Killander D, Sigurdsson H: Proliferation and DNA ploidy in malignant breast tumors in relation to early oral contraceptive use and early abortion. Cancer 67: 1285–1290, 1991Google Scholar
  26. 26.
    Brinton LA, Daling JR, Liff JM, Schoenberg JB, Malone KE, Stanford JL, Coates RJ, Gammon MD, Hanson L, Hoover RN: Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst 87: 827–835, 1995Google Scholar
  27. 27.
    Bondy ML, Newman LA: Breast cancer risk assessment models: applicability to African-American women. Cancer 97(Suppl): 230–235, 2003Google Scholar
  28. 28.
    Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, Gumpper KL, Scholl T, Tavtigian SV, Pruss DR, Critchfield GC: Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10, 000 individuals. J Clin Oncol 20: 1480–1490, 2002Google Scholar
  29. 29.
    Panguluri RC, Brody LC, Modali R, Utley K, Adams-Campbell L, Day AA, Whitfield-Broome C, Dunston GM: BRCA1 mutations in African Americans. Hum Genet 105: 28–31, 1999Google Scholar
  30. 30.
    Olopade OI, Fackenthal JD, Dunston G, Tainsky MA, Collins F, Whitfield-Broome C: Breast cancer genetics in African Americans. Cancer 97(Suppl): 236–245, 2003Google Scholar
  31. 31.
    Haga S, Fu S, Karp JE, Ross DD, Williams DM, Hankins WD, Behm F, Ruscetti FW, Chang M, Smith BD, Becton D, Raimondi SC, Berg PE: BP1, a new homeobox gene, is frequently expressed in acute leukemias. Leukemia 14: 1867–1875, 2000Google Scholar
  32. 32.
    Fu S, Schwartz A, Stevenson H, Pinzone JJ, Davenport GJ, Orenstein JM, Gutierrez P, Simmens SJ, Abraham J, Poola I, Stephan DA, Berg PE: Correlation of expression of BP1, a homeobox gene, with estrogen receptor status in breast cancer. Breast Cancer Res 5: R82–87, 2003Google Scholar
  33. 33.
    Fu S, Stevenson H, Strovel JW, Haga SB, Stamberg J, Do K, Berg PE: Distinct functions of two isoforms of a homeobox gene, BP1 and DLX7, in the regulation of the beta-globin gene. Gene 278: 131–139, 2001Google Scholar
  34. 34.
    Poola I, Clarke R, DeWitty R, Leffall LD: Functionally active estrogen receptor isoform pro les in the breast tumors of African American women are different from the pro les in breast tumors of Caucasian women. Cancer. 94: 615–623, 2002Google Scholar
  35. 35.
    Gospodarowicz MK, Henson DE, Hutter RVP, O 'sullivan B, Sobin LH, Wittekind C (eds): Prognostic Factors in Cancer. International Union Against Cancer, 2nd edn. Wiley Liss, NY, 2001Google Scholar
  36. 36.
    Dayal HH, Power RN, Chiu C: Race and socio-economic status in survival from breast cancer. J Chronic Dis 35: 675–683, 1982Google Scholar
  37. 37.
    Vernon SW, Tilley BC, Neale AV, Steinfeldt L: Ethnicity, survival, and delay in seeking treatment for symptoms of breast cancer. Cancer 55: 1563–1571, 1985Google Scholar
  38. 38.
    Diehr P, Yergan J, Chu J, Feigl P, Glaefke G, Moe R, Bergner M, Rodenbaugh J: Treatment modality and quality differences for black and white breast-cancer patients treated in community hospitals. Med Care 27: 942–958, 1989Google Scholar
  39. 39.
    Smedley BD, Stith A, Nelson AR (eds): Unequal Treatment –Confronting Racial and Ethnic Disparities in Health Care. Institute of Medicine, National Academy Press, Washington, DC, 2002Google Scholar
  40. 40.
    Jatoi I, Becher H, Leake CR: Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U.S.Department of Defense Healthcare system. Cancer 98: 894–899, 2003Google Scholar
  41. 41.
    Wojcik BE, Spinks MK, Optenberg SA: Breast carcinoma survival analysis for African American and white women in an equal-access health care system. Cancer 82: 1310–1318, 1998Google Scholar
  42. 42.
    Dignam JJ, Redmond CK, Fisher B, Costantino JP, Edwards BK: Prognosis among African American women and white women with lymph node negative breast carci-noma: ndings from two randomized clinical trials of the National Surgical Adjuvant Breast and Bowel Project (NSABP)Cancer 80: 80–90, 1997Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Donald E. Henson
    • 1
  • Steven R. Patierno
    • 2
  1. 1.Department of pathologyThe George Washington; University Cancer InstituteUSA
  2. 2.The George Washington University Cancer InstituteUSA

Personalised recommendations